Fischer Medical Venture L
NSE: FISCHER · Medical Equipment & Supplies · sector
₹27.00NSE close 2026-10-26
Key numbers
Market cap₹856 cr
Price₹27.00
52w high / low₹122 / ₹23
P/E11.2xSector median 20.2x
P/B2.2xSector median 2.6x
Book value₹12.1
Dividend yield0.04%Sector median 0.24%
ROE-0.8%Sector median 12.4%
ROCE11.6%Sector median 13.5%
OPM13.6%Sector median 13.8%
Debt / equity0.19xSector median 0.13x
EV/EBITDA18.1xSector median 16.4x
Interest cover6.1x
Current ratio1.62x
Sales growth 3y–Sector median +12.9%
Profit growth 3y–Sector median +4.1%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹25 cr vs borrowings ₹72 cr (FY26): borrowings are higher by ₹47 cr.
- Operating profit covered interest 6.1x in the last 12 months.
- 6.81% of the promoters' shares are pledged (4.3% of all shares).
- Promoter holding rose by 1.28 percentage points in a year, to 63.08% (2026-09-30).
- Net loss in 2 of the last 5 quarters.
- Dividend paid in 1 of the last 1 financial years.
- Price ₹27.00 on 2026-10-26: -77.8% from the 52-week high, +15.8% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹115.70 · low ₹27.00
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 23 | 86 | 101 | 98 | 82 |
| EBITDA | 4 | 16 | 22 | 1 | 11 |
| OPM % | 18.2% | 18.8% | 21.3% | 1.0% | 13.7% |
| Other income | 7 | 2 | 1 | 1 | 1 |
| Net profit | 5 | -0 | 0 | -7 | 4 |
| EPS (₹) | 0.08 | 2.15 | 0.30 | -0.11 | 0.06 |
| Revenue YoY | +249.5% | ||||
| Profit YoY | -24.4% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 309 | 367 |
| EBITDA | 43 | 50 |
| Net profit | 31 | -3 |
| EPS (₹) | 0.48 | 2.40 |
| Dividend / share (₹) | 0.01 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | -74.8% |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 384 |
| Borrowings | 72 |
| Cash & equivalents | 25 |
| Total assets | 671 |
| Fixed assets | 12 |
| Capital work in progress | 3 |
| Investments | 118 |
| Receivables | 289 |
| Inventory | 13 |
| Payables | 103 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | -101 |
| Cash from investing | -5 |
| Cash from financing | 14 |
| Capex | 1 |
| Free cash flow | -103 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 8.1% |
| ROCE % | 11.5% |
| Debtor days | 342 |
| Inventory days | 32 |
| Payable days | 263 |
| Cash conversion cycle (days) | 111 |
| Working capital days | 189 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 63.08% |
| FIIs | 6.71% |
| DIIs | 1.26% |
| of which Mutual funds | 0.00% |
| Public (non-institutions) | 28.94% |
| Quarter | Jul 2025 | Sep 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 61.80% | 61.80% | 61.80% | 61.80% | 62.15% | 62.15% | 63.08% | 63.08% |
| Promoter group | % |
|---|---|
| FMV Holdings Pte Ltd | 50.78% |
| Shankar Varadharajan | 12.31% |
| KS Smart Technologies Ltd | 0.00% |
| Ravindran Govindan | 0.00% |
| Mercatus Capital Pte Ltd | 0.00% |
| Time Medical Holdings Company Ltd | 0.00% |
| Eight Mercatus PTE. Ltd | 0.00% |
| Neuome Peptides PTE Ltd | 0.00% |
| Mercatus Medtech PTE Ltd | 0.00% |
| Infinite Diagnostics PTE Ltd | 0.00% |
| Eight Mighty Ventures PTE Ltd | 0.00% |
| Eight NDX Ventures PTE Ltd | 0.00% |
| Public holders above 1% | % |
|---|---|
| Vikasa India EIF I Fund | 2.81% |
| Roopal Hitesh Kawa . | 2.47% |
| India Emerging Giants Fund Limited | 2.32% |
| Maybank Securities PTE Ltd - ODI | 1.43% |
| Blue Lotus Capital Multi Bagger Fund II | 1.26% |
| Vinay Rajendrakumar Nagda | 1.16% |
| Natwarlal Keshavjibhai Kawa | 1.11% |
| Vritti Hitesh Kawa . | 1.03% |
| Hitesh Natwarlal Kawa | 1.02% |
25,676 shareholders. Pledged: 6.81% of promoter shares.
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-09-22 | Dividend | Dividend - Re 0.05 Per Share |
| 2025-09-22 | Dividend | Dividend - Rs 0.005 Per Share |
| 2025-09-12 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY25
- Annual report FY25
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Manufacturing and Trading: Medical devices and software including radiology and preventive and other healthcare devices
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | FISCHER |
| BSE code | 524743 |
| ISIN | INE771F01041 |
| Face value | ₹1.0 |
| Incorporated | 1993-03-22 |
| Website | www.fischermv.com |
| Plants (India / abroad) | 1 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.